Fate Therapeutics
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
12278 Scripps Summit Dr, San Diego, Cali...Phone Number
(858) 875-1800Website
www.fatetherapeutics.comRevenue
$6.3 MillionStock Symbol
FATEIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
4
1
1
1
1
1
About Fate Therapeutics
Fate Therapeutics, established in 2007 and headquartered in San Diego, California, is a clinical-stage biopharmaceutical company focused on developing innovative cellular immunotherapies. The company specializes in research and development of treatments for cancer and immune disorders, utilizing advanced cellular technology to create therapeutic solutions. As a publicly traded organization, Fate Therapeutics continues to advance its pipeline of cellular immunotherapy products through various clinical trials, working to address significant unmet medical needs in oncology and immunology.Explore more
Popular SearchesFate Therapeutics IncFate TherapeuticsFate Therapeutics LtdFate IncFate Therapeutics (UK) LtdSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: FATEShow moreFate Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Fate Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Fate Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Fate Therapeutics recently announced quarterly report
Check if Fate Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Fate Therapeutics is spiking on competitors!
Product Launch: Get notified when Fate Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Fate Therapeutics
Fate Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Fate Therapeutics has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Fate Therapeutics
Compare insights from companies similar to Fate Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Fate Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Fate Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Fate Therapeutics.
Fate Therapeutics financials insights
Gather financial insights about Fate Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Stock Offering
$40.4M
2014
Debt
$20M
2015
Stock Offering
$32M
2016
Share Placement
$10.3M
Share Placement
$57M
2017
Stock Offering
$42.9M
2018
Grant
$4M
Stock Offering
$143.8M
2019
Stock Offering
$173.1M
Fate Therapeutics Tech Stack
A closer look at the technologies used by Fate Therapeutics
See more technologies
Most Recent Scoops
Person-Based
Medical Research, Pharmaceuticals
Open Position
Person-Based
Medical Research, Pharmaceuticals, Clinical Operations
Person-Based
Medical Research, Pharmaceuticals, Accessibility
Earnings
Earnings, Finance
Fate Therapeutics News & Media
Fate Therapeutics to Present Preliminary Clinical Data of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Sclerosis at the ISSCR 2026 Annual Meeting
SAN DIEGO, July 06, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies broadly to patients with cancer and autoimmune disease, today announced that preliminary clinical data from the Company’s off-the-shelf CAR T-cell product candidate, FT819, will be presented at the International Society for Stem Cell Research (ISSCR)Fate Therapeutics to Participate in Upcoming Third Quarter 2026 Conferences
SAN DIEGO, July 01, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that management will participate in the following investor conferences in the third quarter of 2026.Fate Therapeutics Appoints Laura Hamill to Board of Directors
Accomplished global commercial operations leader brings deep experience launching and scaling biopharmaceutical products as Fate advances its pipeline toward commercialization Accomplished global commercial operations leader brings deep experience launching and scaling biopharmaceutical products as Fate advances its pipeline toward commercializationAfter CAR-T, the Next Frontier in Cancer Immunotherapy May Belong to a Different Immune Cell
Issued on behalf of GT Biopharma, Inc.
Read more news
Top Manufacturing Companies
Frequently Asked Questions Regarding Fate Therapeutics
Sign Up For FreeTo access detailed company insights
Fate Therapeutics, established in 2007 and headquartered in San Diego, California, is a clinical-stage biopharmaceutical company focused on developing innovative cellular immunotherapies. The company specializes in research and development of treatments for cancer and immune disorders, utilizing advanced cellular technology to create therapeutic so... Read More
